Cargando...

Resistance to BRAF inhibitors: Unraveling mechanisms and future treatment options

The MAPK pathway has emerged as a central target for melanoma therapy due to its persistent activation in the majority of tumors. Several BRAF inhibitors aimed at curbing MAPK pathway activity are currently in advanced stages of clinical investigation. However, their therapeutic success is limited b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Villanueva, Jessie, Vultur, Adina, Herlyn, Meenhard
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3588168/
https://ncbi.nlm.nih.gov/pubmed/22131348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-1243
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!